The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
SOCIAL CAP HEDOSOPHIA HLDGS | *W EXP 09/14/202 | G8250R129 | 910 | 1,166,666 | SH | SOLE | 1,166,666 | 0 | 0 | ||
NABORS INDUSTRIES LTD | 6% PFD CNV SR A | G6359F129 | 8,337 | 309,115 | SH | SOLE | 309,115 | 0 | 0 | ||
SOCIAL CAP HEDOSOPHIA HLDGS | CL A | G8250R103 | 35,665 | 3,499,998 | SH | SOLE | 3,499,998 | 0 | 0 | ||
STONECO LTD | COM CL A | G85158106 | 2,508 | 61,000 | SH | DFND | 1 | 0 | 61,000 | 0 | |
STONECO LTD | COM CL A | G85158106 | 2,508 | 61,000 | SH | Put | DFND | 1 | 0 | 61,000 | 0 |
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 2,940 | 82,300 | SH | DFND | 1 | 0 | 82,300 | 0 | |
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 2,940 | 82,300 | SH | Put | DFND | 1 | 0 | 82,300 | 0 |
ELASTIC N V | ORD SHS | N14506104 | 1,518 | 19,000 | SH | DFND | 1 | 0 | 19,000 | 0 | |
ELASTIC N V | ORD SHS | N14506104 | 1,518 | 19,000 | SH | Put | DFND | 1 | 0 | 19,000 | 0 |
FIAT CHRYSLER AUTOMOBILES N | SHS | N31738102 | 25,472 | 1,711,262 | SH | Put | SOLE | 1,711,262 | 0 | 0 | |
SPOTIFY TECHNOLOGY S A | SHS | L8681T102 | 116,199 | 837,171 | SH | SOLE | 837,171 | 0 | 0 | ||
COCA COLA EUROPEAN PARTNERS | SHS | G25839104 | 17,693 | 341,952 | SH | SOLE | 341,952 | 0 | 0 | ||
SOCIAL CAP HEDOSOPHIA HLDGS | UNIT 99/99/9999 | G8250R111 | 0 | 2 | SH | SOLE | 2 | 0 | 0 |